Orphazyme A/S (CPH: ORPHA)
Denmark
· Delayed Price · Currency is DKK 1,248.40
+49.00 (4.09%)
Oct 1, 2024, 4:47 PM CET
Orphazyme Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Selling, General & Admin | 1.54 | 12.88 | 41.24 | 83.47 | 247.25 | 50.54 | Upgrade
|
| Research & Development | - | - | - | - | 361.28 | 285.41 | Upgrade
|
| Other Operating Expenses | -3.39 | - | - | - | - | - | Upgrade
|
| Operating Expenses | -1.84 | 12.88 | 41.24 | 83.47 | 608.53 | 335.95 | Upgrade
|
| Operating Income | 1.84 | -12.88 | -41.24 | -83.47 | -608.53 | -335.95 | Upgrade
|
| Interest Expense | - | - | - | - | -14.11 | -6.48 | Upgrade
|
| Interest & Investment Income | 0.89 | 0.79 | 0.19 | 0.04 | 0.05 | 0.32 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.21 | 0.21 | - | - | -13.16 | -0.23 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | -0 | 0.6 | -0.43 | Upgrade
|
| EBT Excluding Unusual Items | 2.94 | -11.89 | -41.06 | -83.44 | -635.16 | -342.78 | Upgrade
|
| Legal Settlements | -14.16 | -14.16 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.22 | Upgrade
|
| Pretax Income | -11.42 | -26.05 | -41.06 | -83.44 | -635.16 | -343 | Upgrade
|
| Income Tax Expense | - | - | -2.75 | -4.94 | -1.92 | -5.5 | Upgrade
|
| Earnings From Continuing Operations | -11.42 | -26.05 | -38.31 | -78.5 | -633.25 | -337.5 | Upgrade
|
| Earnings From Discontinued Operations | - | - | 73.38 | -548.04 | - | - | Upgrade
|
| Net Income to Company | - | -26.05 | 35.07 | -626.54 | -633.25 | -337.5 | Upgrade
|
| Net Income | -11.42 | -26.05 | 35.07 | -626.54 | -633.25 | -337.5 | Upgrade
|
| Net Income to Common | -11.42 | -26.05 | 35.07 | -626.54 | -633.25 | -337.5 | Upgrade
|
| Shares Outstanding (Basic) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Shares Change (YoY) | -0.02% | 0.12% | 0.98% | 23.12% | 41.65% | 0.08% | Upgrade
|
| EPS (Basic) | -323.16 | -737.65 | 994.41 | -17939.56 | -22324.12 | -16853.78 | Upgrade
|
| EPS (Diluted) | -323.16 | -737.65 | 994.41 | -17939.56 | -22324.12 | -16853.78 | Upgrade
|
| Free Cash Flow | -8.19 | -20.02 | -117.95 | -602.66 | -541.44 | -329.6 | Upgrade
|
| Free Cash Flow Per Share | -231.73 | -566.97 | -3344.15 | -17255.92 | -19087.68 | -16459.18 | Upgrade
|
| EBITDA | - | -12.1 | -40.46 | -70.26 | -606.45 | -334.21 | Upgrade
|
| D&A For EBITDA | - | 0.78 | 0.78 | 13.21 | 2.08 | 1.75 | Upgrade
|
| EBIT | 1.84 | -12.88 | -41.24 | -83.47 | -608.53 | -335.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.